The estimated Net Worth of Gregory D Waller is at least $1.12 Milion dollars as of 12 August 2020. Mr. Waller owns over 28,630 units of CHF Solutions Inc stock worth over $17,281 and over the last 21 years he sold CHFS stock worth over $1,102,442. In addition, he makes $0 as Independent Director at CHF Solutions Inc.
Gregory has made over 15 trades of the CHF Solutions Inc stock since 2011, according to the Form 4 filled with the SEC. Most recently he sold 28,630 units of CHFS stock worth $2,290 on 12 August 2020.
The largest trade he's ever made was selling 60,000 units of CHF Solutions Inc stock on 10 December 2012 worth over $834,600. On average, Gregory trades about 4,587 units every 72 days since 2003. As of 12 August 2020 he still owns at least 710 units of CHF Solutions Inc stock.
You can see the complete history of Mr. Waller stock trades at the bottom of the page.
Gregory D. Waller serves as Independent Director of the Company. He has served as a director of the Company since August 2011. Mr. Waller also serves on the boards of directors of Endologix Corporation and Arcadia Bioscience, Inc., both publicly traded companies (and as chairman of the audit committees for both companies, a member of the nominating and governance committee for Endologix Corporation and a member of the compensation committee for Arcadia Bioscience, Inc.). Until April 2015, Mr. Waller was chief financial officer of Ulthera Corporation, a privately held company that sells an ultrasound device used for non-invasive brow lifts, which was sold to Merz North America in July 2014. From March 2006 to April 2011, Mr. Waller was chief financial officer of Universal Building Products, Inc., a manufacturer of concrete construction accessories. Mr. Waller served as vice president of finance, chief financial officer, and treasurer of Sybron Dental Specialties, Inc., a manufacturer and marketer of consumable dental products, from August 1993 until his retirement in May 2005, and was formerly vice president and treasurer of Kerr, Ormco Corporation, and Metrex. Mr. Waller joined Ormco in December 1980 as vice president and controller and served as vice president of Kerr European Operations from July 1989 to August 1993. Mr. Waller received an M.B.A. with a concentration in accounting from California State University, Fullerton. His prior board service includes service as a director for the following companies: Alsius Corporation, a publicly traded company (chairman of the audit committee and a member of the compensation committee), from June 2007 until its acquisition by Zoll Medical Corporation in September 2009; Biolase Technology, Inc., a publicly traded company (chairman of the audit committee), from October 2009 to August 2010; Cardiogenesis Corporation, a publicly traded company (chairman of the audit committee), from April, 2007 until its acquisition by Cryolife, in May 2011.
Gregory Waller is 70, he's been the Independent Director of CHF Solutions Inc since 2011. There are 1 older and 7 younger executives at CHF Solutions Inc. The oldest executive at CHF Solutions Inc is John Erb, 71, who is the Chairman of the Board, Chief Executive Officer.
Gregory's mailing address filed with the SEC is C/O ARCADIA BIOSCIENCES, INC., 5950 SHERRY LANE, SUITE 215, DALLAS, TX, 75225.
Over the last 7 years, insiders at CHF Solutions Inc have traded over $74 worth of CHF Solutions Inc stock and bought 366,216 units worth $330,909 . The most active insiders traders include Ki Yong Choi, Gregory D Waller oraz John L Erb. On average, CHF Solutions Inc executives and independent directors trade stock every 97 days with the average trade being worth of $1,485,908. The most recent stock trade was executed by John L Erb on 12 March 2019, trading 9,523 units of CHFS stock currently worth $49,996.
CHF Solutions Inc executives and other stock owners filed with the SEC include: